The study provides genetic evidence that p45v-myb is the transforming protein of avian myeloblastosis virus.
Answers are grounded in this paper and cite their sources.
No immediate clinical implications for leukemia; leaves open p45v-myb mechanisms for further oncogene research.
We have characterized a mutant of avian myeloblastosis virus (strain GA907/7) that shows a reduced capacity to transform myelomonocytic cells at the nonpermissive temperature. Myeloblasts transformed by this mutant suffer a substantial decrease in the amount of the transforming protein p45v-myb when shifted from the permissive to the nonpermissive temperature. We presume that the 5- to 10-fold decrease in the amount of p45v-myb causes the loss of the transformed phenotype. The decrease is due to a reduction in the level of v-myb mRNA. Mutant GA907/7 thus provides genetic evidence that p45v-myb is the transforming protein of avian myeloblastosis virus and apparently represents an unusual defect in the production or stability of mRNA.
No takes yet. Share an insight, caveat, or question.
Moscovici et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: